Metabolic syndrome X is common in Indians: But, why and how?

Journal of Association of Physicians of India

Volumn 51, Issue OCT, 2003, Pages 987-998

  Das, U N ^a  

^a EFA Sciences LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; PROTEIN; SIGNAL PEPTIDE;

HUMAN; INDIA; INFLAMMATION; METABOLIC SYNDROME X; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ADIPONECTIN; HUMANS; INDIA; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; METABOLIC SYNDROME X; OBESITY; PROTEINS;

EID: 1242308920     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (113)

1. McKeigue P, Sevak L. Coronary heart disease in South Asian Communities. London: Health Education Authority, 1994.
2. Bhopal R. Epidemic of cardiovascular disease in South Asians. BMJ 2002;324:625-26.
3. Hansen BC, Jen K-L, Schwartz J. Changes in insulin responses and binding in adipocytes from monkeys with obesity progressing to diabetes. Int J Obes 1988; 12: 433-443.
4. Bjortorp P. Adipose tissue distribution and function. Int J Obes 1991;15(Suppl 2):67-.
5. Pederson O, Hjollund E, Lindskov HO. Insulin binding and action on fat cells from young healthy females and males. Am J Physiol 1982;243:E158-67.
6. Ramos EJB, Xu Y, Romanova I, Middleton F, Chen C, Quinn R, Inui A, Das UN, Meguid MM. Is obesity an inflammatory disease? Surgery, in press.
7. Das UN. Sex differences in the number of adipose cells. XX vs. XY, in press.
8. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001;294:2166-70.
9. Das UN. Metabolic syndrome X is common in South Asians, but why and how? Nutrition 2002;18:774-76.
10. Das UN. Is metabolic syndrome X an inflammatory condition? Exp Biol Med 2002;227:989-97.
11. Das UN. Is obesity an inflammatory condition? Nutrition 2001;17:953-966.
12. Das UN. Obesity, metabolic syndrome X, and inflammation. Nutrition 2002;18:430-432.
13. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham coronary heart disease risk score. Circulation 2003;108:161-5.
14. van der Meer IM, de Maat MPM, Hak AE, et al. C-reactive protein predicts progression of atherosclerosis measured as various sites in the arterial tree. The Rotterdam study. Stroke 2002;33:2750-55.
15. Luc G, Bard J-M, Juhan-Vague I, et al. C-reactive protein, interleukins-6, and fibrinogen as predictors of coronary heart disease. The PRIME study. Arterioscler Thromb Vasc Biol 2003;23:1255-61.
16. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
17. Engstrom G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgarde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003;52:2097-2101.
18. Mosca L. C-reactive protein-to screen or not to screen. N Engl J Med 2002;347:1615-17.
19. Castell JV, Gomez-Lechon MJ, David M, Horano T, Kishimoto T, Heinrich PC. Recombinant human interleukins-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988;232:347-50.
20. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, Tracy RP. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes 2001;50:2384-89.
21. Kirwan JP, Krishnan RK, Weaver JA, Del Aguila LF, Evans WJ. Human aging is associated with altered TNF-(production during hyperglycemia and hyperinsulinemia. Am J Physiol 2001;281:E1137-43.
22. Lin Y, Rajala MW, Berger JP, Moller DE, Barzilai N, Scherer PE. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem 2001;276:42077-83.
23. Hotamisligil GS. The role of TNF-α and TNF receptors in obesity and insulin resistance. J Intern Med 1999;245:621-625.
24. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Role of oxidative stress. Circulation 2002;106:2067-72.
25. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002;75:492-8.
26. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000;85:2970-2973.
27. Mohanty P, Ghanim H, Hamouda W, Aljada A, Garg R, Dandona P. Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 2002;75:767-72.
28. Fan J, Frey RS, Rahman A, Malik AB. Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-α-induced NF-kB activation and intercellular adhesion molecule-1 expression in endothelial cells. J Biol Chem 2002;277: 3404-3411.
29. Mohan IK and Das UN. Oxidant stress, anti-oxidants and nitric oxide in non-insulin dependent diabetes mellitus. Med Sci Res 1997;25:55-57.
30. Das UN. Oxy radicals and their clinical implications. Curr Sci 1993;65:964-8.
31. Kumar KV and Das UN. Lipid peroxides and essential fatty acids in patients with coronary heart disease. J Nutritional Med 1994;4:33-37.
32. Das UN, Kumar KV, Mohan IK. Lipid peroxides and essential fatty acids in patients with diabetes mellitus and diabetic nephropathy. J Nutritional Med 1994;4:149-155.
33. Kumar KV and Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Rad Res Commun 1993;19:59-66.
34. Das UN. Folic acid says NO to vascular diseases. Nutrition 2003;19:686-92.
35. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation 2003;107:391-97.
36. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue. Relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 2003;52:1779-85.
37. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B. Regulation of adiponectin by adipose tissuederived cytokines. In vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003;285:E527-33.
38. Matsubara M, Namioka K, Katayose S. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur J Endocrinol 2003;148:657-62.
39. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003;107:671-74.
40. Hattori Y, Matsumura M, Kasai K. Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res 2003;58:186-195.
41. Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells. Circulation 2003;107:398-404.
42. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360:57-58.
43. Spranger J, Kroke A, Mohlig M, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003;361:226-8.
44. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003;289:1799-1804.
45. Sciacqua A, Candigliota M, Ceravolo R, et al. Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Diabetes Care 2003;26:1673-78.
46. Yatagai T, Nishida Y, Nagasaka S, et al. Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men. Endocr J 2003;50:233-8.
47. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002;106:1439-41.
48. Fernandez-Real JM, Vayreda M, Richart C, et al. Circulating interleukins-6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001;86:1154-59.
49. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 2001;38:399-403.
50. Abramson JL, Weintraub WS, Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 2002;39:197-202.
51. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukins-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 2002;22:1668-73.
52. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity. Circulation Res 2002;91:406-413.
53. Furuhashi M, Ura N, Higashiura K, et al. Blockade of the rennin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003;42:76-81.
54. Das UN. Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-α to prevent human essential hypertension. Eur J Clin Nutr, in press.
55. Snehalatha C, Ramachandran A, Kapur A, Vijay V. Age-specific prevalence and risk association for impaired glucose tolerance in urban Southern Indian population. J Assoc Physicians India 2003;51:766-769.
56. Mohan V, Shanthirani CS, Deepa R. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors-The Chennai Urban Population Study (CUPS 14). J Assoc Physicians India 2003;51:771-77.
57. Joshi SR. Sub clinical diabetes-vascular threat to Asian Indians. J Assoc Physicians India 2003;51:756-7.
58. Diamond J. The double puzzle of diabetes. Nature 2003;423:599-602.
59. Chandalia M, Cabo-Chan AV Jr, Devaraj S, Jialal I, Grundy SM, Abate N. Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. J Clin Endocrinol Metab 2003;88:3773-76.
60. Vikram NK, Misra A, Dwivedi M, et al. Correlations of Creactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis 2003;168:305-13.
61. Jovinge S, Hamsten A, Tomvall P, et al. Evidence for a role of tumor necrosis factor alpha in disturbances of triglycerides and glucose metabolism predisposing to coronary heart disease. Metabolism 1998;47:113-18.
62. Corica F, Allegra A, Corsonello A, et al. Relationship between plasma leptin levels and the tumor necrosis factor alpha system in obese subjects. Int J Obes Metab Disord 1999;23:355-60.
63. Chu N-F, Spiegelman D, Rifai N, et al. Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obes 2000;24:1085-92.
64. Spieker LE, Sudano I, Hurlimann D, et al. High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation 2002;105:1399-402.
65. Denicola A, Batthyany C, Lissi E, et al. Diffusion of nitric oxide into low density lipoprotein. J Biol Chem 2002;277:932-6.
66. Das UN. Nutritional factors in the pathobiology of human essential hypertension. Nutrition 2001;17:337-46.
67. Tomilinson JW, Moore J, Cooper MS, et al. Regulation of expression of 11α-hydroxysteroid dehydrogenase type 1 in adipose tissue: Tissue-specific induction by cytokines. Endocrinology 2001;142:1982-89.
68. Das UN. Is insulin an anti-inflammatory molecule? Nutrition 2001;17:409-13.
69. Das UN. A perinatal strategy for preventing adult disease: The role of long-chain polyunsaturated fatty acids. Kluwer Academic Publishers, Boston, 2002.
70. Jeschke MG, Einspanier R, Klein D, et al. Insulin attenuates the systemic inflammatory response. Mol Med 2002;8:443-50.
71. Gao F, Gao E, Yue T-L, et al. Nitric oxide mediates the anti-apoptotic effect of insulin in myocardial ischemia-reperfusion. The roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002;105:1497-502.
72. Dandona P, Aljada A, Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 2002;45:924-30.
73. Whincup PH, Gilg JA, Papacosta O, et al. Early evidence of ethnic differences in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ 2002;324:1-6.
74. Kalhan R, Puthawala K, Agarwal S, Amini SB, Kalhan SC. Altered lipid profile, leptin, insulin, and anthropometry in offspring of South Asian immigrants in the United States. Metabolism 2001;50:1197-202.
75. Das UN. Pathobiology of metabolic syndrome X in obese and non-obese South Asian Indians: Further discussion and some suggestions. Nutrition 2003;19:560-62.
76. Berenson GS, Srinivasan SR. Prevention of atheroslcerosis in childhood. Lancet 1999;354:1223-24.
77. Barker DJP. Mothers, babies and health in later life. 2nd ed. Edinburgh: Churchill Livingstone, 1998.
78. Barker DJ, Hales CN, Fall CH, et al. Type 2 (non-insulin dependent) diabetes mellitus, hypertension, and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993;36:62-67.
79. Lucas A, Fewtrell MS, Cole TJ. Fetal origins of adult disease- the hypothesis revisited. BMJ 1999;319:245-9.
80. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001;286:1195-200.
81. Krishnaswamy K, Prasad MPR. The changing epidemiologic scene: malnutrition versus chronic diseases in India. Nutrition 2001;17:166-168.
82. Dhawan S. Birth weights of infants of first generation Asian women in Britain compared with second generation Asian women. BMJ 1995;311:86-88.
83. Das UN. The lipids that matter from infant nutrition to insulin resistance. Prostaglandins Leukot Essen Fatty Acids 2002;67:1-12.
84. Das UN. Long-chain polyunsaturated fatty acids in the growth and development of the brain and memory. Nutrition 2003;19:62-65.
85. Das UN. Can memory be improved? A discussion on the role of ras, GABA, acetylcholine, NO, insulin, TNF-α, and long-chain polyunsaturated fatty acids in memory formation and consolidation. Brain Development 2003;25:251-61.
86. Das UN. Essential fatty acids: biology and their clinical implications. Asia Pacific J Pharmacol 1991;16:317-30.
87. Das UN, Horrobin DF, Begin ME, et al. Clinical significance of essential fatty acids. Nutrition 1988;4:337-41.
88. Das UN. Essential fatty acids in health and disease. J Assoc Physicians India 1999;47:906-11.
89. Carlson SE, Werkman SH, Peeples JM, et al. Arachidonic acid status correlates with first year growth in preterm infants. Proc Natl Acad Sci USA 1993;90:1073-77.
90. Yu N, Martin J-L, Stella N, et al. Arachidonic acid stimulates glucose uptake in cerebral cortical astrocytes. Proc Natl Acad Sci USA 1993;90:4042-46.
91. Olsen SF, Olsen J, Frische G. Does fish consumption during pregnancy increase fetal growth? A study of the size of the newborn, placental weight and gestational age in relation to fish consumption during pregnancy. Int J Epidemiol 1990;19:971-7.
92. Baguma-Nibasheka M, Brenna JT, Nathaniesz PW. Delay of preterm delivery in sheep by omega-3 long-chain polyunsaturates. Biol Reprod 1999;60:698-701.
93. Das UN. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus, and coronary heart disease. Prostaglandins Leukot Essen Fatty Acids 1995;52:387-91.
94. Das UN. Essential fatty acids as possible mediators of the actions of statins. Prostaglandins Leukot Essen Fatty Acids 2001;65:37-40.
95. Huang Y-J, Fang VS, Chou Y-C, et al. Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation. Metabolism 1997;46:1252-58.
96. Mori Y, Murakawa Y, Katoh S, et al. Influence of highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous non-insulin dependent diabetes mellitus. Metabolism 1997;46:1458-64.
97. Storlien LH, Pan DA, Kriketos AD, et al. Skeletal muscle membrane lipids and insulin resistance. Lipids 1996;13 (Suppl):S261-65.
98. Borkman M, Storlien LH, Pan DA, et al. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 1993;328:238-44.
99. Reseland JE, Haugen F, Hollung K, et al. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 2001;42:743-50.
100. Das UN, Kumar KV, Ramesh G. Essential fatty acid metabolism in South Indians. Prostaglandins Leukot Essen Fatty Acids 1994;50:253-5.
101. Das UN. Insulin resistance and hyperinsulinemia: are they secondary to an alteration in the metabolism of essential fatty acids. Med Sci Res 1994;22:243-5.
102. Mercuri O, de Tomas E, Itarte H. Prenatal protein depletion and δ9, δ6, and δ5 desaturases in the rat. Lipids 1979;14:822-5.
103. Dhalgren J, Nilsson C, Jennische E, et al. Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol 2001;281:E326-34.
104. Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M, et al. Serum concentrations of TNF-α and soluble TNF-α receptors in obesity. Int J Obesity 2000;24:1392-95.
105. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukins-6: depot differences and regulation by glucocorticoid. J Clin Endocrinol Metab 1998;83:847-50.
106. Seeds MC, Jones DF, Chilton FH, Bass DA. Secretory and cytosoloic phospholipase A2 are activated during TNF priming of human neutrophils. Biochim Biophys Acta 1998;1389:273-84.
107. Wu T, Ikezono T, Angus CW, Shelhamer JH. Tumor necrosis factor-alpha induces the 85-kDa cytosolic phospholipiase A2 gene expression in human bronchial epithelial cells. Biochim Biophys Acta 1996;1310:175-84.
108. Crowl RM, Stoller TJ, Conroy RR, Stoner CR. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 1991;266:2647-51.
109. Dandona P, Mohanty P, Ghanim H, et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 2001;86:355-62.
110. Pischon T, Hankinson SE, Hotamisligil GS, et al. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003;108:155-60.
111. Weisinger HS, Armitage JA, Sinclair AJ, et al. Perinatal omega-3 deficiency affects blood pressure in later life. Nature Med 2001;7:258-9.
112. Can perinatal supplementation of long-chain polyunsaturated fatty acids prevent hypertension in adult life? Hypertension 2001;38:e6-e8.
113. Das UN. Can perinatal supplementation of long-chain polyunsaturated fatty acids prevent diabetes mellitus? Eur J Clin Nutr 2003;57:218-26.